Originally published In Press as doi:10.1074/jbc.M002412200 on April 11, 2000
J. Biol. Chem., Vol. 275, Issue 29, 21817-21826, July 21, 2000
The Saccharomyces cerevisiae RNA-binding Protein
Rbp29 Functions in Cytoplasmic mRNA Metabolism*
Eric
Winstall
§,
Martin
Sadowski¶
,
Uwe
Kühn¶**,
Elmar
Wahle¶**, and
Alan B.
Sachs

From the
Department of Molecular and Cell Biology,
University of California, Berkeley, California 94720 and
¶ Institut für Biochemie, Justus-Liebig-Universität
Giessen, 35392 Giessen, Germany
Received for publication, March 22, 2000
 |
ABSTRACT |
Here we report that the Saccharomyces
cerevisiae RBP29 (SGN1, YIR001C) gene encodes a
29-kDa cytoplasmic protein that binds to mRNA in vivo.
Rbp29p can be co-immunoprecipitated with the poly(A) tail-binding
protein Pab1p from crude yeast extracts in a dosage- and
RNA-dependent manner. In addition, recombinant Rbp29p binds
preferentially to poly(A) with nanomolar binding affinity in
vitro. Although RBP29 is not essential for cell
viability, its deletion exacerbates the slow growth phenotype of yeast
strains harboring mutations in the eIF4G genes TIF4631 and
TIF4632. Furthermore, overexpression of RBP29
suppresses the temperature-sensitive growth phenotype of specific
tif4631, tif4632, and pab1 alleles.
These data suggest that Rbp29p is an mRNA-binding protein that
plays a role in modulating the expression of cytoplasmic mRNA.
 |
INTRODUCTION |
From the time of their synthesis until their degradation, RNA
polymerase II transcripts are associated with proteins. More than just
participating in the packaging of mature or immature mRNAs,
RNA-binding proteins are often actively involved in a series of
post-transcriptional events, such as pre-mRNA 3'-end processing, pre-mRNA splicing, nucleocytoplasmic mRNA export, mRNA
translation, and turnover (for a review, see Ref. 1). Therefore,
RNA-binding proteins are thought to play central roles in the
post-transcriptional regulation of gene expression.
The functions of RNA-binding proteins depend on domains that bind to
RNA and on auxiliary domains involved in protein-protein interactions.
One of the most common RNA-binding domains is the RNA recognition motif
(RRM).1 This motif, conserved
from yeast to human, consists of 80-100 amino acids encompassing a
highly conserved octapeptide known as the ribonucleoprotein consensus
sequence (RNP1) and a hexapeptide termed RNP2 (2-4). Crystal
structures and NMR studies have revealed that RRMs from different
proteins adopt a similar globular tertiary structure in which RNA
binding is primarily supported by
-sheet surfaces (5-9). Some of
the RRM-containing proteins have a basal level of nonspecific binding
affinity for RNA, while others, like the poly(A)-binding protein, show
high affinity for specific RNA sequences.
One important cellular pathway that relies upon RNA-binding proteins is
translation initiation. Translation initiation in eucaryotic cells is
directed by a set of protein-protein and protein-RNA interactions that
promote the recruitment of the 43 S preinitiation complex to the
mRNA (reviewed in Ref. 10). Two key structural elements of most
cellular mRNA, the 5' cap and the 3' poly(A) tail, are important
determinants of these interactions. The translation initiation factor
eIF4E binds to the cap structure, whereas the poly(A) tail-binding
protein (Pab1p) is bound to the poly(A) tail. These two proteins
interact with the translation initiation factor eIF4G. This complex,
along with other factors, is thought to promote the binding of the 43 S
preinitiation complex to mRNAs via the physical interaction between
eIF4G and the ribosome-associated complex eIF3 (reviewed in Ref.
11).
We identified in the Saccharomyces cerevisiae genome data
base a gene (SGN1, YIR001C) encoding an RRM-containing
protein that was highly homologous to poly(A)-binding protein 2 (PABP2), a protein that stimulates the polyadenylation reaction
in vitro by binding to the poly(A) tail and stabilizing the
interaction of poly(A) polymerase with the poly(A) tail (12). Because
of our interests in poly(A) tail-binding proteins, we chose to
investigate the function of this uncharacterized ORF more
closely. Here we report that RBP29 (SGN1,
YIR001C)(RNA-binding protein of
29 kDa) is a cytoplasmic protein that binds to poly(A) with
high affinity. Although it is a nonessential gene, we have discovered
that RBP29 displays genetic interactions with the
translation initiation apparatus. These results suggest that Rbp29p
functions to stimulate the expression of mRNA, possibly through
enhancing the efficiency of translation initiation.
 |
EXPERIMENTAL PROCEDURES |
Yeast Techniques--
Yeast strains (listed in Table I) were
grown on standard YPD or YM medium supplemented with 2% glucose as the
carbon source and the appropriate amino acids and nucleotides (13).
Yeast cells were transformed using the lithium acetate method (14), and
transformants were selected on YM plates containing the appropriate additives.
RBP29 Subcloning and Chromosomal Disruption--
A 2.5-kilobase
pair BclI genomic fragment of chromosome IX containing the
complete ORF of YIR001C (RBP29) was introduced into the
BamHI site of the plasmid pAS246 (URA3 2µ) or of the
plasmid pAS417 (URA3 CEN4) to produce plasmid pRBP29 URA3
2µ (BAS3582) and plasmid pRBP29 URA3 CEN (BAS3583), respectively. To
generate a double hemagglutinin-tagged RBP29 fusion gene
driven by a GAL1-10 promotor, RBP29 was
amplified by PCR using the primer 5'-SalI-P29 (5'-TGATGAGTCGACATGTCCCAGGAAGAGAAAGT; SalI site
underlined) and 3'-HindIII-P29
(5'-TCATCAAAGCTTTTATTTCGAATCTTTTTCTT; HindIII
site underlined). The SalI-HindIII-digested PCR
product was cloned into high copy vector pSEYC68, yielding pHA-RBP29
(BAS3585). Cloning experiments were performed according to established
protocols (15).
One chromosomal copy of the RBP29 gene was replaced by the
one-step gene transplacement method (16) in the diploid yeast strain
YAS2251 (Table I) with the
loxP-kanMX-loxP disruption cassette (17) flanked by short sequences
homologous to position
90 to
50 upstream of the initiation codon
and 40 base pairs following the stop codon of the
RBP29-coding region, respectively. Cells possessing the
integrated loxP-kanMX-loxP cassette were selected on YPD containing a
200 µg/ml concentration of the aminoglycoside antibiotic G418 (Roche
Molecular Biochemicals). Correct integration and disruption of one
RBP29 copy in G418-resistant cells was confirmed by PCR. The
diploid strain bearing one deleted copy of RBP29 was sporulated, and tetrads were dissected to obtain the haploid strain YAS2252.
The strain YAS2620 carrying a disruption in RBP29,
tif4631, and tif4632 was used for the
substitution of the wild type allele of TIF4631 for
tif4631-459, TIF4632, or tif4632-430
on TRP1CEN plasmids by plasmid shuffling on 5-fluoro-orotic
acid (18).
Production of Recombinant Rbp29p and Antibodies--
The
RBP29-coding region was amplified by PCR from genomic DNA
and subcloned into NdeI-BamHI-digested pGM10
(19), yielding plasmid pGM10-H6RBP29 (BAS3584) to allow the expression
of RBP29 under the control of the phage T7 promotor with a
peptide tag (Met-Ala-(His)6) fused to its N terminus.
Escherichia coli strain BL21(DE3)pLysS (20) was transformed
and grown in 0.5 liters of SOB (15) at 37 °C. After induction with 1 mM isopropyl-D-thiogalactopyranoside at a cell
density of A600 = 0.8, the culture was incubated
for 3 h at 37 °C. Cells were harvested; washed in 20 ml of 50 mM Tris-HCl (pH 8.0), 8% sucrose, 5 mM EDTA;
and resuspended in buffer SB (50 mM Tris-HCl (pH 8.0), 300 mM KCl, 10% glycerol, 1 mM PMSF, 1 mM
-mercaptoethanol, 0.1 mM
MgCl2, 0.01% Nonidet P-40, 10 µg/ml DNase I, 2 µg/ml
leupeptin, 2 µg/ml pepstatin). Cells were lysed by sonication, and
the lysate was centrifuged at 20,000 × g for 30 min.
The supernatant was mixed with 1 ml of a 50% slurry of Ni2+-nitrilotriacetic acid-agarose (Qiagen) equilibrated in
buffer A (50 mM Tris-HCl (pH 6.3), 300 mM KCl,
10% glycerol, 1 mM
-mercaptoethanol, 0.01% Nonidet
P-40) and incubated on a shaker for 3 h. The suspension was packed
into a column and washed with 40 ml of buffer SB, and bound protein was
step-eluted with buffer A containing 10, 50, 150, and 500 mM imidazole, respectively. Fractions containing a
polypeptide of ~35 kDa, eluted between 150 and 500 mM
imidazole, were combined, dialyzed against buffer D (20 mM
Hepes (pH 7.9), 50 mM KCl, 10% glycerol, 0.01% Nonidet
P-40, 1 mM dithiothreitol, 2 µg/ml pepstatin, 2 µg/ml
leupeptin, 1 mM PMSF), and loaded onto a Mono S HR 5/5 FPLC
column (Amersham Pharmacia Biotech) equilibrated in the same buffer.
The column was developed with a 75-column volume gradient of 50-1000
mM KCl in buffer D. Rbp29p eluted at 325-375
mM salt. Approximately 1 mg of pure Rbp29p was recovered.
For immunization of rabbits, Rbp29p was purified under denaturing
conditions as described (21). Immunization of two rabbits and
preparation of serum (AK62 and AK63) was performed by Eurogentec. Antibodies were affinity-purified on a
N-hydroxysuccinimide-activated HiTrap affinity column
(Amersham Pharmacia Biotech) according to the manufacturer's
instructions. Despite affinity purification, both sera cross-reacted
with different additional polypeptides of S. cerevisiae.
Filter Binding Assay--
The poly(A) binding activity of Rbp29p
was defined by nitrocellulose filter-binding assays adapted from Ref.
22. The standard reaction contained, in 100 ml, 50 mM
Tris-HCl (pH 8.0), 100 mM KCl, 10% glycerol, 0.2 mg/ml
bovine serum albumin, 0.01% Nonidet P-40, 1 mM EDTA, 0.5 mM dithiothreitol, 0.5 nM end-labeled
A34 or U34. Protein was added to the reaction
mixture on ice and incubated for 15 min at room temperature. The
nitrocellulose filter was washed with 500 ml of buffer W (50 mM Tris-HCl (pH 8.0), 100 mM KCl, 1 mM EDTA) containing 5 µg/ml E. coli rRNA. 80 µl of the reaction mixture was filtered, and the filter was then
washed with 5 µl of ice-cold buffer W. Radioactivity was measured in a liquid scintillation counter. For competition assays, poly(A) was
used at 2.5 ng/reaction, and other polynucleotides were added as indicated.
Measurement of Poly(A) Tail Lengths--
The experiment was
carried out according to Preker et al. (23).
UV Cross-linking in Vivo--
The preparation of cross-linked
RNPs was carried out by modification of a previously described
procedure (see Ref. 24 and references therein). Cells were grown in
1300 ml of YPD medium to an A600 of 10, harvested by centrifugation for 10 min at 5000 × g at
4 °C, washed with ice-cold phosphate-buffered saline (PBS), and
repelleted. The cells were resuspended in 100 ml of ice-cold PBS and
distributed between 6-8 Petri dishes (diameter of 6.5 cm). UV
cross-linking was performed on ice (2 × 2.5 min, UV Stratalinker 1800, Stratagene). The irradiated and nonirradiated (control) cells
were harvested by centrifugation, frozen in liquid nitrogen, and stored
at
80 °C. Cells were lysed in 10 ml of lysis buffer (20 mM Tris-HCl, pH 7.4, 1 mM EDTA, 50 mM LiCl, 1% SDS, 1%
-mercaptoethanol, 5 µg/ml
pepstatin, 5 µg/ml leupeptin, 1 mM PMSF) by extensive vortexing with glass beads (Sigma). After centrifugation for 10 min at
9000 × g, the cleared lysate was mixed with
volume 5 M LiCl and heat-denatured for 10 min
at 65 °C. The lysate was brought to room temperature in a water bath
and again centrifuged for 10 min at 12,500 × g. The
supernatant was batch-incubated for 45 min at room temperature with 400 mg of oligo(dT)-Sepharose (Roche Molecular Biochemicals) equilibrated
in binding buffer (lysis buffer containing 0.5 M LiCl). The
oligo(dT)-Sepharose was then packed into a column. The flow-through
fractions were heat-denatured again and reapplied twice to the column.
The column was washed with 30 ml of binding buffer.
Poly(A)+ material was eluted with 10 ml of lysis buffer
lacking LiCl. RNA-containing fractions (as judged by ethidium bromide
staining) were pooled and brought to 0.5 M LiCl, and the
oligo(dT)-Sepharose column chromatography was repeated without batch
incubation. Eluted poly(A)+ material from the second
chromatography step was recovered by ethanol precipitation. One-half of
the precipitated material was incubated for 2 h at 37 °C in 100 µl of buffer (10 mM Tris-HCl, pH 7.4, 5 mM
CaCl2, leupeptin, pepstatin, and PMSF as above) with 10 µg of RNase A (Sigma) and 300 units of micrococcal nuclease (MBI
Fermentas). After precipitation with 3 volumes of ethanol at
20 °C
overnight, proteins were resolved by SDS-polyacrylamide gel
electrophoresis. Western blot analysis was performed as described (25).
Primary antibodies were diluted 1:1000, and secondary antibodies (Dako)
were diluted 1:5000. For reprobing, the nitrocellulose membrane was
stripped by 2 × 15-min incubation in 200 mM glycine, pH 2.0, 0.1% SDS, and washed twice with water. For control lanes, yeast cells from 1-ml culture volume (A600 = 10)
were harvested by centrifugation, washed with 1 ml of PBS, and then
resuspended in 1 ml of PBS. Cells were lysed by the addition of 150 µl of 1.85 M NaOH, 7.4%
-mercaptoethanol, and
incubation for 10 min on ice. Proteins were precipitated with 150 µl
of 50% trichloroacetic acid and 10-min incubation on ice. After
centrifugation for 2 min in a microcentrifuge, the pellet was washed
once with 1.5 ml of cold 80% acetone, air-dried, and resuspended in 50 µl of SDS sample buffer containing 100 mM Tris. 7 µl
per lane were used for SDS gel electrophoresis.
Immunofluorescence and Microscopy--
Cells (YAS2252)
containing the pHA-RBP29 plasmid (BAS3585) were grown in liquid medium
containing 3% galactose (to induce expression of the HA-RBP29 fusion
gene regulated by the GAL1-10 promoter) to an
A600 of 0.5-1.0 at 30 °C. To 25 ml of
culture, 2.5 ml of 37% formaldehyde were added, and incubation was
continued for 1 h at 30 °C. The cells were put on ice for at
least 60 min, harvested, and resuspended in 100 mM Tris-HCl
(pH 9.4), 10 mM dithiothreitol. The fixed cells were shaken
for 10 min and centrifuged. The pellets were resuspended in 1 ml of
buffer A (50 mM potassium phosphate (pH 7.4), 1.2 M Sorbitol), washed, and resuspended in the same buffer
containing 0.5 mg/ml Zymolyase 100T (Seigakaku Co.). Following
incubation for 30 min at 30 °C, the spheroplasts were centrifuged,
resuspended in 1 ml of buffer A, and centrifuged again at room
temperature. The pellet was resuspended in 50-200 µl of buffer A,
and the viscous suspension was added to
poly-L-lysine-coated coverslips and allowed to dry for 5 min. All subsequent steps were carried out in buffer B (1× PBS, 0.2%
bovine serum albumin, 0.5% Tween 20) at room temperature. The
coverslips were washed four times for 5 min with buffer B and incubated
upside down in 20 µl of buffer B containing the purified monoclonal
mouse antibody 16B12 (Babco) directed against the HA epitope (dilution
was 1:50) for 45 min in a moist chamber. The coverslips were washed as
above and overlaid with 20 µl of Texas Red-conjugated antibodies
directed against mouse IgG (Vector; dilutions 1:100) for 30 min. The
coverslips were washed as above, and 4',6-diamidino-2-phenylindole was
added at a concentration of 0.5 µg/ml in buffer B and incubated for 5 min. The coverslips were washed twice as above, and cells were mounted
in Moviol.
Texas Red and 4',6-diamidino-2-phenylindole were viewed by standard
fluorescence microscopy through a TRITC or UV filter, respectively, on
a Nikon Microphot-FXA.
Immunoprecipitation Experiments--
Yeast extracts for
immunoprecipitation experiments were prepared using a small scale
version of the previously published liquid nitrogen lysis method (26).
Briefly, 100 ml of YPD were inoculated with the appropriate yeast
strain and grown to an A600 of 1.8. Cells were
harvested and washed twice in 50 ml of buffer A (30 mM
Hepes, pH 7.4, 100 mM KOAc, 2 mM MgOAc, 2 mM dithiothreitol). The resulting cell pellet was weighed
and resuspended in
volume of buffer A containing 1 mM PMSF. The suspension was frozen by dripping into liquid
nitrogen. Frozen yeast were crushed in liquid nitrogen using a pestle
and mortar. About 200 mg of frozen yeast powder were transferred to an
Eppendorf tube and allowed to thaw on ice. The lysate was cleared by
two successive centrifugations of 5 min each at 13,000 rpm in an
Eppendorf microcentrifuge at 4 °C. Protein concentration was
determined by the method of Bradford (27) using the Bio-Rad Protein
Assay reagent (Bio-Rad).
For the experiments described in Fig. 2, the anti-Pab1p monoclonal 1G1
antibody (24) was coupled to protein A-Sepharose beads (Repligen) as
described previously (28). 50 µl of a 20% suspension of the
antibody-protein A-Sepharose resin were incubated for 1 h at
4 °C with 500 µg of the extract. The beads were then washed five
times with 1 ml of PBS containing 0.1% Triton X-100 and 0.01% SDS,
and proteins in the immunocomplex were eluted by boiling for 5 min in
30 µl of 2× SDS-polyacrylamide gel electrophoresis loading buffer.
30% of the proteins of the eluate were resolved on a 10%
polyacrylamide gel and analyzed by Western blot analysis as described
previously (28). The polyclonal antibody used to detect Rbp29p was
diluted 1:1000. The monoclonal antibody 1G1 used to detect Pab1p was
diluted 1:2000.
For the experiments involving treatment of the immunoprecipitate with
micrococcal nuclease, beads were first incubated with yeast extracts as
described above. After splitting the bead suspension into two tubes,
the beads were washed three times with PBS containing 1.5 mM CaCl2 (PBS plus CaCl2). The
beads were then incubated 30 min at 4 °C in 200 µl of PBS plus
CaCl2 in the presence or absence of 30 units of micrococcal
nuclease (Pharmacia). Following five washes with PBS containing 0.1%
Triton X-100 and 0.01% SDS, proteins were eluted from the beads as
described above.
[35S]Methionine Incorporation Assays--
This
experiment was performed essentially as described previously (29).
Briefly, cells were grown at 30 °C in selective YMD medium to an
A600 of 0.4. Cells were then incubated at
30 °C or 37 °C for an additional 2-h period. 1.5 ml of culture
were then mixed with 3.5 ml of prewarmed YMD medium containing 60 ng/ml methionine and 0.5 ng/ml [35S]methionine (cell labeling
grade, 1175 Ci/mmol; NEN Life Science Products). The resulting mixture
was incubated at 30 or 37 °C for a 10-min period during which 1-ml
samples (corresponding to each time point) were removed and mixed with
1 ml of 20% trichloroacetic acid. Trichloroacetic acid solutions were
then heated at 95 °C for 20 min, and the protein precipitate was
collected on GFC filters (Whatman). Filters were washed with 10 ml of
10% trichloroacetic acid and then with 10 ml of 95% ethanol and
counted in Scintiverse (Fisher) scintillation fluid. For each
experiment, radioactive counts were corrected for the number of cells
present in the labeling mix. Cell counting was done using a hemocytometer.
 |
RESULTS |
Rbp29p Is Associated with Polyadenylated mRNA in
Vivo--
RBP29 encodes a basic protein of 250 amino acid
residues with a predicted molecular mass of 29 kDa. The protein
sequence contains one putative RNA-binding domain of the RRM type (4).
A BLAST search carried out with the predicted amino acid sequence of
Rbp29p over all indexed protein sequences revealed that it was most
similar to the bovine PABP2. PABP2 is a mammalian protein that
functions as a stimulatory factor for poly(A) polymerase and is
involved in poly(A) tail length control in vitro (12, 30)
and in vivo (31). Rbp29p has an overall sequence identity of
33% (46% similarity) with bovine PABP2. This is due to strong
sequence similarity (43% identity, 62% similarity) in the putative
RNA binding domain, whereas the sequence identity outside this region
is insignificant (below 20%).
UV cross-linking was used to test whether Rbp29p binds to
poly(A)+ mRNA in vivo. Irradiation of living
yeast cells with UV light results in the covalent cross-linking of a
variety of RNA-binding proteins, including Pab1p, Pub1p, Nab2, and
Nab3, to polyadenylated RNAs (3, 24, 32, 33). UV cross-linking
experiments were performed on wild type or rbp29
cells.
RNA was recovered from irradiated or nonirradiated cells and purified
over two rounds of selection on oligo(dT) cellulose. Following RNase
digestion of the bound material, proteins in this mixture were
separated on a gel, transferred to a nitrocellulose membrane, and
detected by Western analysis using antibodies directed against Rbp29p
(see "Experimental Procedures") or the snRNA-associated protein
Snp1 (34). As shown in Fig. 1, Rbp29p was
detected in the poly(A)+ RNA fraction, while Snp1p was not
(compare lanes 2 and 7). In addition,
the isolation of Rbp29p with poly(A)+ RNA was
cross-linking-dependent, since no Rbp29p co-purified with
poly(A)+ RNA from nonirradiated cells (lane
1). As expected, no signal was detected in the
poly(A)+ RNA fraction prepared from irradiated
rbp29
cells (lane 3). These data
show that Rbp29p is associated with mRNA in vivo.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 1.
UV cross-linking of Rbp29p to polyadenylated
cellular RNA. UV cross-linking experiments were performed on wild
type (wt) or rbp29 ( ) cells. RNA was
recovered from irradiated (+) or nonirradiated ( ) cells and purified
over two rounds of selection on oligo(dT)-cellulose. Following RNase
digestion of the bound material, proteins in this mixture and crude
yeast lysates (L) were separated by SDS-polyacrylamide gel
electrophoresis, transferred to a nitrocellulose membrane, and detected
by Western analysis using antibodies directed against Rbp29p or Snp1p,
a snRNA-associated protein. The filled and empty
arrowheads indicate the positions of Rbp29p- and
Snp1p-specific bands, respectively. The marker position and sizes (in
kDa) are indicated on the left.
|
|
The majority of the poly(A) tail-binding protein Pab1p associates with
cytoplasmic mRNA. To determine whether Rbp29p and Pab1p are bound
to the same mRNAs, co-immunoprecipitation experiments were
performed using the anti-Pab1p monoclonal antibody 1G1. Fig. 2 shows that immunoprecipitation of Pab1p
resulted in the co-immunoprecipitation of Rbp29p (Fig. 2A,
lanes 1 and 2). Importantly, higher
levels of Rbp29p in extracts resulted in a concomitant increase in the amount of Rbp29p co-immunoprecipitating with Pab1p (Fig. 2A,
lanes 4 and 5). The specificity of
these assays was confirmed with the observation that Rbp29p was not
detected in immunoprecipitates from extracts containing overexpressed
Rbp29p and a truncated Pab1 protein (pab1-
RRM2) that fails to
interact with the Pab1p antibody (35) (Fig. 2A,
lane 3). Treatment of Pab1p immunocomplexes with
micrococcal nuclease prior to their elution resulted in nearly complete
loss of Rbp29p (Fig. 2B, compare lanes
1 and 2 with lanes 4 and
5). This indicates that the association of Rbp29p with Pab1p requires an RNA component. Overall, these data support the hypothesis that Pab1p and Rbp29p can simultaneously bind to the same mRNA.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 2.
Co-immunoprecipitation of Rbp29p with Pab1p
is dosage- and RNA-dependent. A,
co-immunoprecipitation of Rbp29p and Pab1p. Extracts prepared from
strains containing plasmids bearing the indicated genes were
immunoprecipitated with Pab1p monoclonal antibodies and resolved by
SDS-polyacrylamide gel electrophoresis. Pab1p and Rbp29p in 3% of the
extract and in 30% of the immunoprecipitate (IP) were
detected by Western analysis with Pab1p- or Rbp29p-specific antibodies.
The positions of the Rbp29p and Pab1p proteins on the blots are
indicated. Strains used, lane 1, YAS1956;
lane 2, YAS2136; lane 3,
YAS2629; lane 4, YAS2630; lane
5, YAS2631; lane 6, YAS2620.
B, RNA-dependent interaction between Pab1p
and Rbp29p. Pab1p immunoprecipitates from yeast bearing the indicated
genes were incubated with (+ nuclease) or without
micrococcal nuclease (see "Experimental Procedures") prior to
elution from the Protein A-Sepharose beads. Proteins were
resolved by SDS-polyacrylamide gel electrophoresis, and Rbp29p was
detected by Western analysis.
|
|
Rbp29p Is Localized in the Cytoplasm--
The
co-immunoprecipitation of Rbp29p and Pab1p suggested that Rbp29p is a
cytoplasmic protein. To assess the intracellular localization and
distribution of Rbp29p more directly, fluorescence microscopy analyses
were performed. A yeast strain expressing a gene fusion encoding an
N-terminal hemagglutinin-tagged Rbp29p (HA-RBP29) driven by
the GAL1-10 promoter on a high copy plasmid was examined.
The HA-Rbp29p was strongly overproduced when compared with the level of
wild type Rbp29p (data not shown). Indirect immunofluorescence
microscopy revealed that HA-Rbp29p was localized in the cytoplasm (Fig.
3). Cells containing the
RBP29-HA fusion gene did not react with anti-HA antibody
when synthesis of the fusion protein was repressed by growth on glucose
(data not shown). Similar localization data were obtained using
Rbp29-green fluorescent protein and Rbp29-protein A fusions (data not
shown). Furthermore, cell fractionation studies revealed that Rbp29p,
Hxk1p (hexokinase 1), and Cmd1p (calmodulin 1) were found exclusively
in the cytosolic fraction, whereas Pap1p (poly(A) polymerase) was
detected both in the nuclear and the cytosolic fraction (breakage or
leakage of nuclei can account for Pap1p in the cytoplasmic fraction)
(data not shown). These immunofluorescence and cell fractionation data suggest that Rbp29p is a cytoplasmic protein. In contrast, mammalian PABP2 is localized primarily in the nucleus (36, 37).

View larger version (86K):
[in this window]
[in a new window]
|
Fig. 3.
Rbp29p is localized in the cytoplasm of
cells. Cells expressing a gene fusion encoding an N-terminal
hemagglutinin-tagged Rbp29p (HA-RBP29) driven by the
GAL1-10 promotor were grown in liquid medium containing 3%
galactose. Following fixation and permeabilization, the cells were
incubated with the antibody 16B12 directed against the HA epitope as
described under "Experimental Procedures." A, the
HA-Rbp29 fusion protein was detected using a Texas Red-conjugated
anti-mouse IgG antibody. B, simultaneous staining with
4',6-diamidino-2-phenylindole was utilized to localize the DNA found in
the nucleus and in the mitochondria.
|
|
Rbp29p Binds Preferentially to Poly(A) RNA with High
Affinity--
The in vitro RNA binding properties of Rbp29p
were examined. Rbp29p was expressed in E. coli as a fusion
gene with an N-terminal Met-Ala-His6 tag. A two-step
purification by Ni2+-nitrilotriacetic acid chromatography
followed by anion exchange chromatography (see "Experimental
Procedures") resulted in a homogeneous preparation (data not shown).
Mass spectroscopy of several column fractions gave molecular masses of
29,781 and 29,831 Da, in reasonable agreement with the expected
molecular mass of 29,791 Da for the tagged protein (data not shown).
Western analysis using the anti-Rbp29p antibody and known amounts of
purified recombinant Rbp29p allowed us to approximate that Rbp29p is
present at about 0.03% of total proteins in an S30 yeast lysate (data
not shown). This is about 15 times less than the amount of Pab1p, which
is estimated to be present at about 0.5% of total proteins in an S30
lysate (38).
Nitrocellulose filter-binding assays with purified recombinant Rbp29p
were performed. The homopolymers A34 and U34
were used as ligands. As shown in Fig.
4A, in the presence of 100 mM KCl, recombinant Rbp29p bound most tightly to poly(A)
(apparent KD = 1 nM). The affinity for
poly(U) was lower by approximately 500-fold. With decreasing salt
concentration, Rbp29 binding to RNA became progressively nonspecific
(data not shown).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 4.
Rbp29p exhibits specific, high affinity
binding to poly(A). A, binding of Rbp29p to RNA
homopolymers. Nitrocellulose filter-binding assays were carried out
with the indicated amounts of Rbp29p and radiolabeled RNA as described
under "Experimental Procedures." RNA homopolymers were as follows:
A34 ( ) and U34 ( ). B,
specificity of poly(A) binding by Rbp29p. Rbp29p (1.5 nM)
was incubated with radiolabeled poly(A) (2.5 ng) and unlabeled
competitor RNA present at the excess over labeled poly(A) as indicated
(0.4, 1, 4, 20, 40, 200). Rbp29p-poly(A) complexes were detected by
nitrocellulose filter binding as described under "Experimental
Procedures." Competitors were A34 ( ), C34
( ), G34 ( ), dA ( ), and rRNA ( ).
|
|
The binding specificity of Rbp29p for poly(A) was confirmed by
competition experiments using A34 as the radiolabeled
ligand (Fig. 4B). E. coli ribosomal RNA and
poly(G) were relatively efficient competitors, with binding to poly(A)
being reduced to 50% at a 5-10-fold excess of competitor. In
contrast, a 200-fold excess of poly(C) as competitor reduced binding of
radiolabeled poly(A) by only 20%. As a control, unlabeled poly(A)
competed for binding approximately as expected. Poly(dA) caused no
detectable reduction in poly(A) binding even at a 200-fold excess.
Therefore, Rbp29p has no significant affinity for single-stranded DNA.
Taken together with the data shown in Fig. 4A, these results
show that Rbp29p is an RNA-binding protein that has a high affinity for
poly(A) in vitro.
Deletion of RBP29 Does Not Change Poly(A) Tail Length Distributions
in Vivo--
The significant homology of Rbp29p to PABP2 and its
preference for binding to poly(A) RNA prompted us to investigate
whether it functioned in some aspect of poly(A) tail metabolism.
Temperature-sensitive mutations in yeast genes encoding proteins
involved in mRNA 3'-end processing result in a rapid loss of
polyadenylated RNA at the restrictive temperature in vivo
(23, 39-42). In contrast, mutations in Pab1p and the
Pab1p-dependent poly(A) nuclease, consisting of the
subunits Pan2p and Pan3p, result in abnormally long poly(A) tails
in vivo (43-45) and in vitro (40, 45, 46). We
thus investigated whether deletion of RBP29 resulted in
aberrant poly(A) tail lengths on mRNA.
Total RNA prepared from exponentially growing wild type and
rbp29
cells was labeled at the 3'-end and subjected to
RNase A and T1 digestion, which leaves only the poly(A) tails intact. As shown in Fig. 5, poly(A) tails on
mRNA from wild type (lane 3) and
rbp29
cells (lane 4) reached the
same maximal length of approximately 70 nucleotides, which corresponds
to the tail lengths previously reported (47). In addition,
rbp29
cells showed no significant differences in the
pattern of the poly(A) tail length distribution as compared with wild
type cells. Thus, the absence of Rbp29p does not have a detectable
influence on the poly(A) tail length of mRNA in vivo. In
addition, extracts prepared from wild type or rbp29
cells
were found to cleave and polyadenylate a pre-mRNA substrate with
the same efficiency (data not shown). These data strongly suggest that
Rbp29p is not involved in the 3'-end processing or subsequent poly(A)
metabolism of mRNA. Since RBP29 is the only ORF of
S. cerevisiae with significant homology to PABP2, these
results may indicate that yeast does not have a protein that functions
as PABP2.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 5.
Deletion of Rbp29p does not affect mRNA
poly(A) tail lengths in vivo. Poly(A) tails on
mRNA derived from either wild type (RBP29) or mutant
(rbp29 ) yeast strains were 3'-end-labeled with
[32P]cordycepin, resolved on a polyacrylamide gel, and
visualized by autoradiography (see "Experimental Procedures").
A70, size-selected A65-75;
L3pre(A)40, polyadenylated in vitro
transcribed mRNA that was subject to the same treatments as the
total RNA. The marker position and sizes (in nucleotides) are indicated
on the left.
|
|
RBP29 Overexpression Suppresses the Temperature Sensitivity of
Various tif4631, tif4632, and pab1 Alleles--
Although
RBP29 encodes a cytoplasmic RNA-binding protein, it is a
nonessential gene whose deletion results in very little change in the
growth characteristics of the yeast. A yeast strain that depends upon
Rbp29p for normal growth would be invaluable for future studies on
Rbp29p, since it would allow for an in vivo analysis of its
function. Toward this goal, we pursued our observation that
overexpression of RBP29 leads to scorable phenotypes in
different yeast translation mutants.
S. cerevisiae contains two homologs of eIF4G that are
encoded by the genes TIF4631 (eIF4G1) and TIF4632
(eIF4G2) (48). We have previously described an extensive analysis of
the in vitro and in vivo consequences of
mutations in the eIF4E-binding domain of these two eIF4G homologs
(49-51). Briefly, replacement of two highly conserved leucine residues
with alanine within the eIF4E-binding region of either eIF4G1
(tif4631-459) or eIF4G2 (tif4632-430) severely
impairs the association of eIF4E with eIF4G in vitro. Moreover, yeast strains carrying the tif4631-459 or the
tif4631-430 allele as their sole source of eIF4G display a
temperature-sensitive growth phenotype at 37 °C that is suppressed
by increasing the expression of eIF4E or by removing Caf20p, a
negative regulator of eIF4E (50).
We found that overexpression of RBP29 on a yeast 2µ
plasmid also suppressed the temperature-sensitive phenotype of the
tif4631-459 strain at 37 °C (Fig.
6A). This suppression,
although easily scored, was much weaker than that observed when eIF4E
is overexpressed or when CAF20 is deleted (data not shown).
To test whether suppression by excess Rbp29p was specific for the
tif4631-459 mutation, yeast strains bearing
temperature-sensitive alleles of different translation initiation
factors were transformed with RBP29 on a 2µ plasmid and
placed at 37 °C. As seen in Fig. 6A and Table
II, suppression of temperature
sensitivity by excess RBP29 was observed in strains carrying
alleles of eIF4G1 (tif4631-427) and eIF4G2
(tif4632-430) that are deficient in binding to eIF4E (50,
52). In contrast, excess RBP29 did not suppress the
temperature sensitivity of conditional alleles of TIF4632
(tif4632-1, tif4632-6, and
tif4632-8) that are defective in eIF4A binding (53), of the
tif4631-454 allele (49) that more fully destroys eIF4E
binding to eIF4G1, or of the eIF4E temperature-sensitive allele
cdc33-1 (54). Excess Rbp29p also did not suppress the
temperature sensitivity of a tif1-1 strain, which contains
a mutation in the eIF4A protein (55). These data suggest that
RBP29-mediated suppression of temperature sensitivity is an
allele-specific effect.

View larger version (66K):
[in this window]
[in a new window]
|
Fig. 6.
Excess RBP29
suppresses the temperature sensitivity of
tif4631, tif4632, and pab1
mutants. A multicopy plasmid with no insert (empty 2µ) or
the yeast RBP29 gene on either a multicopy (2µ) or a
centromeric (CEN) plasmid were transformed into the
tif4631-459 (YAS2074) and tif4632-430 (YAS2002)
mutants (A) and into the pab1-F364L (YAS120)
mutant (B). A photograph of the minimal medium plates after
7 days at 30 or 37 °C is shown.
|
|
We have previously shown that a loss-of-function allele of the
PAB1 gene (pab1-16) is synthetically lethal with
the eIF4E mutation cdc33-1. This suggested that Pab1p and
eIF4E have functional redundancy (49). Given our observation that
overexpression of RBP29 was able to rescue the temperature
sensitivity of specific tif4631 and tif4632
mutations that result in poor binding to eIF4E, we decided to test if
excess RBP29 also suppressed the conditional growth defect
of a pab1 mutant.
RBP29 on a 2µ vector was introduced into a strain carrying
the pab1-F364L allele. This gene encodes a Pab1 protein that
lacks its first three RRMs and has a phenylalanine to leucine
substitution in the remaining RRM4 (2). Importantly, this mutant form
of Pab1p does not contain the RRM2 domain, which is required for the
functional interaction of Pab1p with eIF4G (35) and for the
Pab1p-mediated transactivation of cap-dependent translation in vitro (26). This form of Pab1p also confers a
temperature-sensitive growth phenotype to cells (2). As shown in Fig.
6B, excess RBP29 suppressed the
temperature-sensitive phenotype of the pab1-F364L strain.
Incubation at the restrictive temperature of serial dilutions of midlog
cultures of the pab1-F364L strain bearing RBP29
on a 2µ plasmid confirmed that the observed suppression was due to the presence of excess RBP29 and not the appearance of
spontaneous suppressors of pab1-F364L (data not shown).
Together with the ability of RBP29 to suppress the
temperature-sensitive phenotype of the tif4631 and
tif4632 mutants, our observation that RBP29
overexpression suppresses the temperature-sensitive phenotype of
pab1-F364L provides a simple assay to elucidate the functional domains of Rbp29p in the future. It also suggests strongly that Rbp29p is involved in controlling the expression of cytoplasmic mRNA, since its overexpression allows for cell growth in the
presence of an inadequate translation initiation apparatus.
Deletion of RBP29 Results in a Synthetic Slow Growth Phenotype When
Combined with tif4631 and tif4632 Mutations--
Having established
that RBP29 function could be evaluated by monitoring its
ability to suppress various tif4631, tif4632, and
pab1 alleles, we next sought to identify conditions where a
deletion of RBP29 resulted in a scorable growth phenotype.
We found that the growth characteristics of the RBP29
deletion mutant were not significantly different from those of a wild
type strain under a variety of conditions, including different
temperatures or carbon sources, osmotic stress, and exposure to
formamide, ethanol, or caffeine. Sporulation and germination efficiency
were also not affected by this deletion. We thus chose to search for a
growth phenotype associated with a deletion of RBP29 in the presence of mutations within the eIF4G genes.
As shown in Fig. 7, A and
B, deletion of RBP29 in strains having only
eIF4G1 or eIF4G2 as their source of eIF4G (see "Experimental Procedures") resulted in viable cells having the same growth rate as
the control strain at 30 °C. However, when serial dilutions of
cultures were incubated at 37 °C, these strains displayed a growth
rate significantly slower than the parental stains containing an intact
genomic copy of RBP29. This synthetic slow growth phenotype observed at 37 °C but not at 30 °C shows that Rbp29p is required for optimal growth at higher temperature when only one of the two yeast
eIF4G homologues is available.

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 7.
Synthetic slow growth phenotypes of
rbp29 in combination with
tif4631 or tif4632 mutations.
Strains carrying a normal or a disrupted allele of RBP29 and
either the TIF4631 (A), TIF4632
(B), tif4631-459 (C), or
tif4632-430 (D) gene as their sole source of
eIF4G were grown to stationary phase in minimal medium. Serial
dilutions (1:5) of the cultures were prepared, and equal numbers of
cells from each strain were plated on a minimal medium and incubated at
30 or 37 °C for 5 days.
|
|
When the wild type version of TIF4631 was replaced with the
tif4631-459 allele, cells deleted for RBP29
showed a slower growth at 30 °C when compared with the parental
strain containing the tif4631-459 allele and intact
RBP29 (Fig. 7C). Deletion of RBP29 in
a strain having the tif4632-430 allele also resulted in a
subtle slower growth rate at 30 °C (Fig. 7D). This milder
effect most probably reflects the weaker phenotype associated with the
tif4632-430 allele (50). As expected, the
rbp29
tif4631-459 and rbp29
tif4632-430 double mutants exhibited temperature-sensitive
phenotypes when incubated at 37 °C (data not shown). Deletion of
RBP29 in a strain producing an eIF4G1 protein that fails to
interact with Pab1p (tif4631-
N300; see Ref. 49) also
resulted in a significant slow growth phenotype at 30 °C (data not shown).
In conjunction with the above high copy suppression data, these results
support the hypothesis that Rbp29p normally functions to enhance the
expression of mRNA. Under conditions where translation initiation
is operating with limiting eIF4G levels, the function of Rbp29p appears
to become more important for cells to retain their normal growth rates.
Rpb29p Overexpression Does Not Restore Normal Levels of Translation
to tif4631-459 Strains--
The above results indicated that
RBP29 plays a role in modulating the expression of
cytoplasmic RNA. We next chose to determine whether RBP29
overexpression enhanced the ability of tif4631-459 mutants
to translate mRNA more efficiently. We thus measured the rate of
[35S]methionine incorporation into protein in
tif4631-459 cells expressing normal or high levels of
Rbp29p. These rates were compared with the rate of incorporation of
cells bearing a wild type copy of TIF4631.
Cultures in midlog phase were incubated for 2 h at 30 or 37 °C
and labeled with [35S]methionine for 10 min. Fig.
8 shows that, even at the permissive temperature, cells carrying the tif4631-459 allele had
[35S]methionine incorporation rates that were
significantly lower than that observed for the wild type cells.
Surprisingly, following a 2-h incubation period at the restrictive
temperature (37 °C), the tif4631-459 cells continued to
incorporate [35S]methionine at about the same rate as
they had at 30 °C. Longer incubation times at 37 °C (up to 6 h) gave similar results (data not shown). Excess Rbp29p in the
tif4631-459 cells led to only a small increase in the rate
of [35S]methionine incorporation at both 30 and
37 °C.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 8.
Overexpression of RBP29
does not suppress the translational deficiency of
tif4631-459 strains. Strains carrying
TIF4631 (YAS1956), tif4631-459 (YAS2074), or
tif4631-459 and RBP29 on a 2µ vector
(tif4631 + 2µ RBP29) (YAS2618) were grown at
30 °C and then incubated at 30 or 37 °C for an additional 2-h
period. The rate of [35S]methionine incorporation into
protein was then measured as described under "Experimental
Procedures."
|
|
These results show that cells carrying the tif4631-459
allele have a reduced rate of protein synthesis at both the permissive and nonpermissive temperatures and that excess Rbp29p does not restore
these rates to a significant degree. One important ancillary conclusion
that can be drawn from these data is that shifting tif4631-459 cells from the permissive to the restrictive
temperature does not induce a general arrest of translation.
Since high copy suppression by excess Rbp29p appeared specific to eIF4G
mutants defective in their binding to eIF4E (Table II), we tested the
hypothesis that excess Rbp29p may increase the binding of eIF4E to
eIF4G1-459. We found that the amount of eIF4E co-immunoprecipitating
with eIF4G was the same in extracts prepared from
tif4631-459 cells expressing either a normal or high level
of Rbp29p (data not shown). We also tested the possibility that a high
level of Rbp29p could suppress the temperature-sensitive growth
phenotype of the tif4631-459 strain by increasing or
decreasing the intracellular level of translation initiation factors or
regulators. Western blot analysis using specific antibodies directed
against eIF4G1, eIF4E, eIF4A, Caf20p, and Pab1p showed that the
levels of these proteins were similar in extracts from
tif4631-459 cells having a normal or high level of Rbp29p
(data not shown).
Other results did not favor the hypothesis that RBP29 is
involved in global control of protein synthesis. First, polysomal profiles of rbp29
cells were identical to those of the
parental wild type cells. Second, there was no difference in the rate
of translation of luciferase reporter mRNAs added to extracts
prepared from rbp29
or wild type cells (data not shown).
Third, extracts prepared from tif4631-459 cells expressing
a high level of Rbp29p displayed the same in vitro
translation characteristics as those observed using
tif4631-459 extracts with normal Rbp29p levels. Finally,
the addition of recombinant Rbp29p to translation extracts prepared
from the tif4631-459 strain did not result in any
significant changes in the translation of the different luciferase
reporter mRNAs (data not shown). Our results also do not favor the
hypothesis that Rbp29p might be involved in the global control of
mRNA decay. We found that the half-life and the degradation pattern
of the unstable MFA2 mRNA in rbp29
cells
were nearly identical to those observed in wild type cells (data not shown).
These results indicate that RBP29 overexpression probably
does not suppress the temperature-sensitive growth phenotype of the
tif4631-459 strain by stimulating a general increase in
translation. Instead, it may do so by increasing the expression of a
subset of mRNAs whose limited expression at increased temperature
results in the growth arrest phenotype.
 |
DISCUSSION |
This study presents the characterization of S. cerevisiae Rbp29p, previously known to be a nonessential 29-kDa
protein containing one RRM domain (56). Rbp29p was found to be a
cytoplasmic RNA-binding protein that is associated with
poly(A)+ RNAs in vivo. It is also associated
with Pab1p in crude yeast extracts in a dosage- and
RNA-dependent manner. In vitro, recombinant Rbp29p shows high binding affinity for poly(A). Although cells lacking
Rbp29p have no discernible phenotype, we discovered that deletion of
the RBP29 gene worsens the slow growth phenotype of tif4631 and tif4632 mutants. Moreover, excess
Rbp29p suppresses the temperature-sensitive phenotype associated with
tif4631, tif4632, and pab1 alleles.
These data suggest that Rbp29p plays a stimulatory role in mRNA
expression, possibly by affecting the efficiency of translation of a
subset of transcripts.
RBP29 is a member of a family of about 45 genes in S. cerevisiae that encode proteins encompassing at least one RRM
domain. Its localization to the cytoplasm, its interaction with
cytoplasmic Pab1p, and its genetic interaction with the translation
machinery make it a bona fide member of a small group of
yeast cytoplasmic RRM-containing proteins. These include translation
initiation factors eIF4B (Tif3p), the
-subunit of eIF3 (Prt1p), and
eIF4G as well as the mRNA-binding proteins Pab1p and Pub1p.
Despite having exhibited a function in mRNA expression, Rbp29p in
crude yeast extracts did not co-sediment with polyribosomes in sucrose
gradients (data not shown). This might be explained if Rbp29p binds to
the coding region of mRNA and has to dissociate from the transcript
to allow for the passage of the ribosomes. It is important to note that
although Rbp29p has high affinity for poly(A) in vitro (Fig.
4), there is no direct evidence that Rbp29p is bound to the poly(A)
tail of mRNAs in vivo. In fact, our results showing that
rRNA can efficiently compete with poly(A) for Rbp29p binding (Fig.
4B) could indicate that Rbp29p functions as a more general
RNA-binding protein. However, it should also be noted that the poly(A)
binding of mammalian PABP2, which is homologous to Rbp29p, is also
competed by rRNA (12).
The present study extends the characterization of the
tif4631-459 mutant by showing that even at the permissive
temperature, this strain has a highly reduced rate of protein
synthesis. Shifting the cell to the restrictive temperature (37 °C)
does not result in a further significant reduction of these rates.
Based on these results, it seems likely that the growth arrest of the
tif4631-459 mutant at 37 °C is a consequence of a
reduction in the rate of translation of subset of mRNAs whose
products are required for progression through the cell cycle. This pool
of mRNAs could include transcripts that are normally poorly
translated or whose steady state levels are reduced at higher
temperature. One possibility is that Rbp29p functions to ensure the
optimal level of expression of such a subpopulation of mRNAs.
Consistent with this idea are our results showing that Rbp29p is
required for optimal growth at higher temperature when only one of the
two yeast eIF4G homologues is available (Fig. 7, A and
B). This requirement for Rbp29p is also evident at 30 °C
when eIF4G cannot interact properly with the cap-binding protein (Fig.
7C) or with Pab1p (data not shown).
Rbp29p could work in dosage suppression of the tif4631-459
temperature sensitivity either by inducing a general increase in mRNA translatability or by increasing the expression of a specific subset of transcripts. Our observation that the amount of Rbp29p co-immunoprecipitating with Pab1p is dependent on the amount of Rbp29p
present in the cell is consistent with the hypothesis that it functions
as a dosage suppressor as a result of its increased binding to
mRNA. Whether this increased binding leads to more efficient
mRNA export, mRNA translation, mRNA stabilization, or some
other process will only be known when the mRNAs whose expression is
stimulated by Rbp29p are identified.
In conclusion, we have characterized a nonessential RNA-binding protein
and provided clues about its possible function in cytoplasmic mRNA
metabolism. Our identification of genetic interactions between
mutations in RBP29 and TIF4631 and
TIF4632 now provide useful tools for further investigations
of the role of Rbp29p in yeast. Together with the anticipated progress
in understanding the cellular roles of other poorly characterized yeast
RNA-binding proteins, our work should provide a basis for the
development of a more complete model of how mRNA packaging
functions to regulate gene expression in eucaryotes.
 |
ACKNOWLEDGEMENTS |
We thank Reinhard Lührmann for the
antibody against Snp1p; Anne Nemeth for help with initial experiments;
Lionel Minvielle for discussions, advice, and help with experiments;
and Walter Keller for support. We also thank members of the Sachs
laboratory for help and advice.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant GM50308 (to A. B. S.) and by funding from the Deutsche
Forschungsgemeinschaft, the TMR program of the European Union, and the
Fonds der Chemischen Industrie to Elmar Wahle.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported by a postdoctoral fellowship from The Natural Sciences
and Engineering Research Council of Canada.
Present address: Dept. of Cell Biology, Biozentrum, University
of Basel, Klingelbergstr. 70, 4056 Basel, Switzerland.
**
Present address: Institut für Biochemie,
Martin-Luther-Universität Halle, 06099 Halle, Germany.

To whom correspondence should be addressed: Dept. of Molecular
and Cell Biology, 401 Barker Hall, University of California, Berkeley,
CA 94720. Tel.: 510-643-7698; Fax: 510-643-5035; E-mail: asachs@uclink4.berkeley.edu.
Published, JBC Papers in Press, April 11, 2000, DOI 10.1074/jbc.M002412200
 |
ABBREVIATIONS |
The abbreviations used are:
RRM, RNA recognition
motif;
RNP, ribonucleoprotein;
ORF, open reading frame;
PCR, polymerase
chain reaction;
PMSF, phenylmethylsulfonyl fluoride;
PBS, phosphate-buffered saline;
HA, hemagglutinin.
 |
REFERENCES |
| 1.
|
Siomi, H.,
and Dreyfuss, G.
(1997)
Curr. Opin. Genet. Dev.
7,
345-353
|
| 2.
|
Sachs, A. B.,
Davis, R. W.,
and Kornberg, R. D.
(1987)
Mol. Cell. Biol.
7,
3268-3276
|
| 3.
|
Adam, S. A.,
Nakagawa, T.,
Swanson, M. S.,
Woodruff, T. K.,
and Dreyfuss, G.
(1986)
Mol. Cell. Biol.
6,
2932-2943
|
| 4.
|
Burd, C. G.,
and Dreyfuss, G.
(1994)
Science
265,
615-621
|
| 5.
|
Allain, F. H.,
Howe, P. W.,
Neuhaus, D.,
and Varani, G.
(1997)
EMBO J.
16,
5764-5772
|
| 6.
|
Oubridge, C.,
Ito, N.,
Evans, P. R.,
Teo, C. H.,
and Nagai, K.
(1994)
Nature
372,
432-438
|
| 7.
|
Price, S. R.,
Evans, P. R.,
and Nagai, K.
(1998)
Nature
394,
645-650
|
| 8.
|
Handa, N.,
Nureki, O.,
Kurimoto, K.,
Kim, I.,
Sakamoto, H.,
Shimura, Y.,
Muto, Y.,
and Yokoyama, S.
(1999)
Nature
398,
579-585
|
| 9.
|
Deo, R. C.,
Bonanno, J. B.,
Sonenberg, N.,
and Burley, S. K.
(1999)
Cell
98,
835-845
|
| 10.
|
Gingras, A.-C.,
Raught, B.,
and Sonenberg, N.
(1999)
Annu. Rev. Biochem.
68,
913-963
|
| 11.
|
Sachs, A. B.,
Sarnow, P.,
and Hentze, M. W.
(1997)
Cell
89,
831-838
|
| 12.
|
Wahle, E.
(1991)
Cell
66,
759-768
|
| 13.
|
Guthrie, C.,
and Fink, G.
(1991)
Methods Enzymol.
194,
3-21
|
| 14.
|
Gietz, R. D.,
Schiestl, R. H.,
Willems, A. R.,
and Woods, R. A.
(1995)
Yeast
11,
355-360
|
| 15.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 16.
|
Orr-Weaver, T. L.,
Szostak, J. W.,
and Rothstein, R. J.
(1981)
Proc. Natl. Acad. Sci. U. S. A.
78,
6354-6358
|
| 17.
|
Guldener, U.,
Heck, S.,
Fielder, T.,
Beinhauer, J.,
and Hegemann, J. H.
(1996)
Nucleic Acids Res.
24,
2519-2524
|
| 18.
|
Boeke, J. D.,
Trueheart, J.,
Natsoulis, G.,
and Fink, G.
(1987)
Methods Enzymol.
154,
164-175
|
| 19.
|
Martin, G.,
and Keller, W.
(1996)
EMBO J.
15,
2593-2603
|
| 20.
|
Studier, F. W.
(1991)
J. Mol. Biol.
219,
37-44
|
| 21.
|
Benoit, B.,
Nemeth, A.,
Aulner, N.,
Kühn, U.,
Simonelig, M.,
Wahle, E.,
and Bourbon, H. M.
(1999)
Nucleic Acids Res.
27,
3771-3778
|
| 22.
|
Sachs, A. B.,
and Kornberg, R. D.
(1985)
Mol. Cell. Biol.
5,
1993-1996
|
| 23.
|
Preker, P. J.,
Lingner, J.,
Minvielle-Sebastia, L.,
and Keller, W.
(1995)
Cell
81,
379-389
|
| 24.
|
Anderson, J. T.,
Wilson, S. M.,
Datar, K. V.,
and Swanson, M. S.
(1993)
Mol. Cell. Biol.
13,
2730-2741
|
| 25.
|
Körner, C. G.,
Wormington, M.,
Muckenthaler, M.,
Schneider, S.,
Dehlin, E.,
and Wahle, E.
(1998)
EMBO J.
17,
5427-5437
|
| 26.
|
Otero, L.,
Ashe, M.,
and Sachs, A.
(1999)
EMBO J.
18,
3153-63
|
| 27.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254
|
| 28.
|
Tarun, S. Z.,
and Sachs, A. B.
(1996)
EMBO J.
15,
7168-7177
|
| 29.
|
Sachs, A. B.,
and Deardorff, J. A.
(1992)
Cell
70,
961-973
|
| 30.
|
Nemeth, A.,
Krause, S.,
Blank, D.,
Jenny, A.,
Jenö, P.,
Lustig, A.,
and Wahle, E.
(1995)
Nucleic Acids Res.
23,
4034-4041
|
| 31.
|
Chen, Z.,
Li, Y.,
and Krug, R. M.
(1999)
EMBO J.
18,
2273-2283
|
| 32.
|
Anderson, J.,
Paddy, M.,
and Swanson, M.
(1993)
Mol. Cell. Biol.
13,
102-112
|
| 33.
|
Wilson, S. M.,
Datar, K. V.,
Paddy, M. R.,
Swedlow, J. R.,
and Swanson, M. S.
(1994)
J. Cell Biol.
127,
1173-1184
|
| 34.
|
Fabrizio, P.,
Esser, S.,
Kastner, B.,
and Lührmann, R.
(1994)
Science
264,
261-265
|
| 35.
|
Kessler, S. H.,
and Sachs, A. B.
(1998)
Mol. Cell. Biol.
18,
51-57
|
| 36.
|
Calado, A.,
Kutay, U.,
Kühn, U.,
Wahle, E.,
and Carmo-Fonseca, M.
(2000)
RNA
6,
245-256
|
| 37.
|
Krause, S.,
Kakan, S.,
Weis, K.,
and Wahle, E.
(1994)
Exp. Cell Res.
214,
75-82
|
| 38.
|
Tarun, S.,
and Sachs, A. B.
(1995)
Genes Dev.
9,
2997-3007
|
| 39.
|
Minvielle-Sebastia, L.,
Winsor, B.,
Bonneaud, N.,
and Lacroute, F.
(1991)
Mol. Cell. Biol.
11,
3075-3087
|
| 40.
|
Amrani, N.,
Minet, M.,
Le Gouar, M.,
Lacroute, F.,
and Wyers, F.
(1997)
Mol. Cell. Biol.
17,
3694-3701
|
| 41.
|
Kessler, M. M.,
Henry, M. F.,
Shen, E.,
Zhao, J.,
Gross, S.,
Silver, P. A.,
and Moore, C. L.
(1997)
Genes Dev.
11,
2545-2556
|
| 42.
|
Patel, D.,
and Butler, J. S.
(1992)
Mol. Cell. Biol.
12,
3297-3304
|
| 43.
|
Sachs, A. B.,
and Davis, R. W.
(1989)
Cell
58,
857-67
|
| 44.
|
Boeck, R.,
Tarun, S., Jr.,
Rieger, M.,
Deardorff, J. A.,
Muller-Auer, S.,
and Sachs, A. B.
(1996)
J. Biol. Chem.
271,
432-438
|
| 45.
|
Brown, C. E.,
and Sachs, A. B.
(1998)
Mol. Cell. Biol.
18,
6548-6559
|
| 46.
|
Minvielle-Sebastia, L.,
Preker, P. J.,
Wiederkehr, T.,
Strahm, Y.,
and Keller, W.
(1997)
Proc. Natl. Adac. Sci. U. S. A.
94,
7897-7902
|
| 47.
|
Groner, B.,
and Phillips, S. L.
(1975)
J. Biol. Chem.
250,
5640-5646
|
| 48.
|
Goyer, C.,
Altmann, M.,
Lee, H. S.,
Blanc, A.,
Deshmukh, M.,
Woolford, J. L.,
Trachsel, H.,
and Sonenberg, N.
(1993)
Mol. Cell. Biol.
13,
4860-4874
|
| 49.
|
Tarun, S. Z.,
Wells, S. E.,
Deardorff, J. A.,
and Sachs, A. B.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
9046-9051
|
| 50.
|
Tarun, S. Z.,
and Sachs, A. B.
(1997)
Mol. Cell. Biol.
17,
6876-6886
|
| 51.
|
Wells, S. E.,
Hillner, P.,
Vale, R.,
and Sachs, A. B.
(1998)
Mol. Cell
2,
135-140
|
| 52.
|
Hershey, P. E. C.,
McWhirter, S. M.,
Gross, J. D.,
Wagner, G.,
Alber, T.,
and Sachs, A. B.
(1999)
J. Biol. Chem.
274,
21297-21304
|
| 53.
|
Neff, C.,
and Sachs, A. B.
(1999)
Mol. Cell. Biol.
19,
5557-5564
|
| 54.
|
Brenner, C.,
Nakayama, N.,
Goebl, M.,
Tanaka, K.,
Tohe, A.,
and Matsumoto, K.
(1988)
Mol. Cell. Biol.
8,
3556-3559
|
| 55.
|
Schmid, S. R.,
and Linder, P.
(1991)
Mol. Cell. Biol.
11,
3463-3471
|
| 56.
|
Entian, K.-D.,
Schuster, T.,
Hegemann, J. H.,
Becher, D.,
Feldmann, H.,
Güldener, U.,
Götz, R.,
Hansen, M.,
Hollenberg, C. P.,
Jansen, G., W., K.,
Klein, S.,
Kötter, P.,
Kricke, J.,
Launhardt, H.,
Mannhaupt, G.,
Maierl, A.,
Meyer, P.,
Mewes, W.,
Munder, T.,
Niedenthal, R. K.,
Ramezani Rad, M.,
Röhmer, A.,
Römer, A.,
Rose, M.,
Schäfer, B.,
Siegler, M.-L.,
Vetter, J.,
Wilhelm, N.,
Wolf, K.,
Zimmermann, F. K.,
Zollner, A.,
and Hinnen, A.
(1999)
Mol. Gen. Genet.
262,
683-702
|
| 57.
|
Altmann, M.,
and Trachsel, H.
(1989)
Nucleic Acids Res.
17,
5923-5931
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit<